Filtros de búsqueda

Lista de obras de Fabien Zoulim

A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infection.

artículo científico publicado en 2018

A Model-Based Illustrative Exploratory Approach to Optimize the Dosing of Peg-IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy

artículo científico publicado en 2014

A global scientific strategy to cure hepatitis B

scientific article published on 10 April 2019

A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus.

artículo científico publicado en 2004

A novel hepatitis B virus mutation with resistance to adefovir but not to tenofovir in an HIV-hepatitis B virus-co-infected patient.

artículo científico publicado en 2006

A quasi-monoclonal anti-HBs response can lead to immune escape of 'wild-type' hepatitis B virus.

artículo científico publicado en 2005

A research agenda for curing chronic hepatitis B virus infection.

artículo científico publicado en 2017

A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook

artículo científico publicado en 2022

Acyclic nucleoside thiophosphonates as potent inhibitors of HIV and HBV replication

artículo científico publicado en 2011

Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepatitis B.

artículo científico publicado en 2009

Adefovir serum levels do not differ between responders and nonresponders

artículo científico publicado en 2011

Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.

artículo científico publicado en 2013

Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line.

artículo científico publicado en 2009

An immortalized human liver endothelial sinusoidal cell line for the study of the pathobiology of the liver endothelium

artículo científico publicado en 2014

Analogs combination therapy in chronic hepatitis B: when and how? ⬇️

artículo científico publicado el 1 de septiembre de 2010

Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy.

artículo científico publicado en 2004

Anti-E1E2 antibodies do predict response to triple therapy in treatment-experienced Hepatitis C Virus-cirrhosis cases

artículo científico publicado en 2015

Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy.

artículo científico publicado en 2018

Antiviral Therapy in Patients with Hepatitis C Virus-Induced Cirrhosis

artículo científico publicado en 2015

Antiviral activity of various interferons and pro-inflammatory cytokines in non-transformed cultured hepatocytes infected with hepatitis B virus

artículo científico publicado en 2016

Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles.

artículo científico publicado en 2006

Antiviral therapies and prospects for a cure of chronic hepatitis B.

artículo científico publicado en 2015

Antiviral therapy of chronic hepatitis B: prevention of drug resistance.

artículo científico publicado en 2007

Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?

artículo científico publicado en 2007

Are novel combination therapies needed for chronic hepatitis B?

artículo científico publicado en 2012

Assessment of treatment efficacy in HBV infection and disease.

artículo científico publicado en 2005

Association of Metabolic Risk Factors With Risks of Cancer and All-Cause Mortality in Patients With Chronic Hepatitis B

artículo científico publicado en 2020

Association of anti-E1E2 antibodies with spontaneous recovery or sustained viral response to therapy in patients infected with hepatitis C virus ⬇️

artículo científico publicado el 1 de noviembre de 2010

Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure.

artículo científico publicado en 2010

Author Correction: Therapeutic strategies for hepatitis B virus infection: towards a cure

scientific article published on 01 April 2020

Autoimmunization induced by interferon alpha therapy in chronic hepatitis C

artículo científico publicado en 2004

BAY 41-4109-mediated aggregation of assembled and misassembled HBV capsids in cells revealed by electron microscopy

scientific article published on 11 July 2019

Baseline interpatient hepatitis B viral diversity differentiates HBsAg outcomes in patients treated with tenofovir disoproxil fumarate.

artículo científico publicado en 2014

Benefit of direct-acting antiviral therapy for hepatitis C virus (HCV) in monoinfected and HIV-HCV-coinfected patients with mixed cryoglobulinaemia

article

Biological basis for functional cure of chronic hepatitis B

artículo científico publicado en 2019

Boceprevir and telaprevir-based triple therapy for chronic hepatitis C: virological efficacy and impact on kidney function and model for end-stage liver disease score

artículo científico publicado en 2014

Bridging basic science and clinical research: the EASL Monothematic Conference on Translational Research in Viral Hepatitis.

artículo científico publicado en 2014

CD8+T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction

scientific article published on 31 October 2019

CD81 large extracellular loop-containing fusion proteins with a dominant negative effect on HCV cell spread and replication.

artículo científico publicado en 2017

Can We Predict Sustained Virologic Response to Interferon α Therapy in Patients With Chronic Hepatitis Delta Virus Infection?

artículo científico publicado en 2015

Can we cure hepatitis B virus with novel direct-acting antivirals?

artículo científico publicado en 2020

Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel.

artículo científico publicado en 2008

Challenges to a Cure for HBV Infection.

artículo científico publicado en 2017

Characterization of Pattern Recognition Receptor Expression and Functionality in Liver Primary Cells and Derived Cell Lines

artículo científico publicado en 2018

Characterization of a new sensitive PCR assay for quantification of viral DNA isolated from patients with hepatitis B virus infections

artículo científico publicado en 2007

Characterization of hepatitis B virus surface antigen variability and impact on HBs antigen clearance under nucleos(t)ide analogue therapy

artículo científico publicado en 2016

Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model.

artículo científico publicado en 2000

Chronic Hepatitis B Virus Infection: Disease Revisit and Management Recommendations

artículo científico publicado en 2016

Clearance of serum HBsAg and anti-HBs seroconversion following antiviral therapy for chronic hepatitis B.

artículo científico publicado en 2009

Cleaved c-FLIP mediates the antiviral effect of TNF-α against hepatitis B virus by dysregulating hepatocyte nuclear factors.

artículo científico publicado en 2015

Clinical consequences of hepatitis C virus infection.

artículo científico publicado en 2003

Clinical evaluation of the branched DNA assay for hepatitis B virus DNA detection in patients with chronic hepatitis B lacking hepatitis B e antigen and treated with interferon-alpha.

artículo científico publicado en 1998

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

scientific article published on 11 February 2019

Clinical relevance of the study of hepatitis B virus covalently closed circular DNA.

artículo científico

Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays.

artículo científico publicado en 2004

Combination of nucleoside analogues in the treatment of chronic hepatitis B virus infection: lesson from experimental models.

artículo científico publicado en 2005

Comparison between Elecsys HBsAg II and architect HBsAg QT assays for quantification of hepatitis B surface antigen among patients coinfected with HIV and hepatitis B virus.

artículo científico publicado en 2011

Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients

artículo científico publicado en 2008

Control of hepatitis B virus replication by innate response of HepaRG cells.

artículo científico publicado en 2010

Critical role of the 36-nucleotide insertion in hepatitis B virus genotype G in core protein expression, genome replication, and virion secretion.

artículo científico publicado en 2007

Current Management Strategies for Hepatitis B in the Elderly

artículo científico publicado el 1 de enero de 2001

Current and emerging therapeutic approaches to hepatitis C infection.

artículo científico publicado en 2003

Current hepatitis delta virus type 1 (HDV1) infections in central and eastern Turkey indicate a wide genetic diversity that is probably linked to different HDV1 origins.

artículo científico publicado en 2012

Current treatments for chronic hepatitis B virus infections

artículo científico publicado en 2016

Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme.

artículo científico publicado en 2017

Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients

artículo científico publicado en 2016

Decreased infectivity of nucleoside analogs-resistant hepatitis B virus mutants.

artículo científico publicado en 2012

Delta infection in chronic HBs Ag carriers in Tunisia: high prevalence in chronic asymptomatic HBs Ag carriers and in HBs Ag positive cirrhosis.

artículo científico publicado en 1990

Design and evaluation of hepatitis B virus inhibitors.

artículo científico publicado en 2000

Detection of pre-S1 proteins in peripheral blood mononuclear cells from patients with HBV infection ⬇️

artículo científico publicado el 1 de marzo de 1991

Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector

artículo científico publicado en 2017

Development of hepatocellular carcinoma in chronic hepatitis B patients with advanced fibrosis is independent of viral genotype.

artículo científico publicado en 2016

Different forms of hepatitis B virus DNA and expression of HBV antigens in peripheral blood mononuclear cells in chronic hepatitis B.

artículo científico publicado en 1990

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes.

artículo científico publicado en 2018

Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C.

artículo científico publicado en 2017

Direct-acting antivirals and viral RNA targeting for hepatitis B cure

artículo científico publicado en 2020

Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study

artículo científico publicado en 2020

Disruption of calcium transfer from ER to mitochondria links alterations of mitochondria-associated ER membrane integrity to hepatic insulin resistance.

artículo científico publicado en 2015

Diversity of hepatocellular carcinoma clones bearing hematopoietic malignancies-related chromosomal translocation

artículo científico publicado en 2014

Does occult HBV infection have an impact on the evolution of chronic hepatitis C?

artículo científico publicado en 2013

Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy.

artículo científico publicado en 1998

Drug-resistant and immune-escape HBV mutants in HIV-infected hosts.

artículo científico publicado en 2010

Duck hepatitis B virus primary hepatocyte culture model.

artículo científico publicado en 2004

Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B

artículo científico publicado en 2019

EASL recognition awardee 2013: Professor Yun-Fan Liaw.

artículo científico publicado en 2013

Early detection of hepatitis B drug resistance: implications for patient management ⬇️

artículo científico publicado el 1 de septiembre de 2003

Early inhibition of hepatocyte innate responses by hepatitis B virus.

artículo científico publicado en 2015

Early treatment of acute hepatitis C with interferon alpha-2b or interferon alpha-2b plus ribavirin: study of sixteen patients

artículo científico publicado en 2003

Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC study

artículo científico publicado en 2015

Editorial overview: Antiviral strategies: Antiviral drug design: creating new ideas against old and new bugs.

artículo científico publicado en 2017

Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infection.

artículo científico publicado en 2004

Effect of hepatitis B virus (HBV) surface-gene variability on markers of replication during treated human immunodeficiency virus-HBV infection in Western Africa

artículo científico publicado en 2018

Effect of mutating the two cysteines required for HBe antigenicity on hepatitis B virus DNA replication and virion secretion.

artículo científico publicado en 2005

Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hep

artículo científico publicado en 2017

Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytes.

artículo científico publicado en 2005

Efficacy and safety of simeprevir with PegIFN/ribavirin in naïve or experienced patients infected with chronic HCV genotype 4.

artículo científico publicado en 2015

Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter study.

artículo científico publicado en 2011

Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study

artículo científico publicado en 2017

Emerging drugs for hepatitis B.

artículo científico publicado en 2007

End points of therapy in chronic hepatitis B.

artículo científico publicado en 2010

Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement

artículo científico publicado en 2009

Enhanced magnitude and breadth of neutralizing humoral response to a DNA vaccine targeting the DHBV envelope protein delivered by in vivo electroporation.

artículo científico publicado en 2012

Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: An international multicenter cohort study

scientific article published on 26 October 2011

Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failure.

artículo científico publicado en 2016

Epidermal Growth Factor Receptor-Dependent Mutual Amplification between Netrin-1 and the Hepatitis C Virus.

artículo científico publicado en 2016

Ester prodrugs of acyclic nucleoside thiophosphonates compared to phosphonates: synthesis, antiviral activity and decomposition study

artículo científico publicado en 2013

Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus.

artículo científico publicado en 2006

Ethics and hepatitis B cure research.

artículo científico publicado en 2016

European multicenter evaluation of high-density DNA probe arrays for detection of hepatitis B virus resistance mutations and identification of genotypes

artículo científico publicado en 2006

Evolution and suppression of HBV strains with multidrug resistance to lamivudine, adefovir dipivoxil and entecavir in a patient with chronic hepatitis B.

artículo científico publicado en 2010

Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate.

artículo científico publicado en 2013

Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy.

artículo científico publicado en 2004

Evolution of hepatitis B virus polymerase gene sequence during famciclovir therapy for chronic hepatitis B.

artículo científico publicado en 2000

Expression and functionality of Toll- and RIG-like receptors in HepaRG cells.

artículo científico publicado en 2015

Extra hepatic cancers are the leading cause of death in cirrhotic patients achieving HBV control or HCV eradication.

artículo científico publicado en 2018

FIG4 is a hepatitis C virus particle-bound protein implicated in virion morphogenesis and infectivity with cholesteryl ester modulation potential.

artículo científico publicado en 2015

Factors associated with pandemic influenza A/H1N1 vaccine coverage in a French cohort of HIV-infected patients.

artículo científico publicado en 2011

Favorable course of hepatitis B virus reactivation with hepatocellular insufficiency by a treatment combining corticoids, foscarnet and ganciclovir

artículo científico publicado en 1997

Full-length 5'RACE identifies all major HBV transcripts in HBV-infected hepatocytes and patient serum

artículo científico publicado en 2020

Genetic vaccination for production of DNA-designed antibodies specific to Hepadnavirus envelope proteins.

artículo científico publicado en 2005

Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.

artículo científico publicado en 2003

Genome-wide identification of direct HBx genomic targets

scientific article (publication date: 17 February 2017)

Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection.

artículo científico publicado en 2010

Global strategies are required to cure and eliminate HBV infection.

artículo científico publicado en 2016

Glucosidase inhibitors as antiviral agents for hepatitis B and C.

artículo científico publicado en 2007

Glutathione peroxidase 4 is reversibly induced by HCV to control lipid peroxidation and to increase virion infectivity

artículo científico publicado en 2014

Going towards more relevant cell culture models to study the in vitro replication of serum-derived hepatitis C virus and virus/host cell interactions?

artículo científico publicado en 2006

Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference

artículo científico publicado en 2019

Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡

artículo científico publicado en 2019

Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma.

artículo científico publicado en 2017

HBV cure: why, how, when?

artículo científico publicado en 2016

HBV/HDV co-infection in the Western Brazilian Amazonia: an intriguing mutation among HDV genotype 3 carriers.

artículo científico publicado en 2014

HBVdb: a knowledge database for Hepatitis B Virus.

artículo científico publicado en 2012

HBsAg quantification: virological significance

artículo científico publicado en 2010

HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes

artículo científico publicado en 2016

Hepatitis A outbreak in HIV-infected MSM and in PrEP-using MSM despite a high level of immunity, Lyon, France, January to June 2017.

artículo científico publicado en 2017

Hepatitis B

scientific article published on 20 September 2018

Hepatitis B and hepatitis D virus infections in the Central African Republic, twenty-five years after a fulminant hepatitis outbreak, indicate continuing spread in asymptomatic young adults

artículo científico publicado en 2018

Hepatitis B cure: From discovery to regulatory approval.

artículo científico publicado en 2017

Hepatitis B cure: From discovery to regulatory approval.

artículo científico publicado en 2017

Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriers.

artículo científico publicado en 2011

Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production

artículo científico publicado en 2020

Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection.

artículo científico publicado en 2011

Hepatitis B virus activity in untreated hepatitis B e antigen-negative human immunodeficiency virus-hepatitis B virus co-infected patients from sub-Saharan Africa

artículo científico publicado en 2019

Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity.

artículo científico publicado en 2007

Hepatitis B virus genetic variability and evolution.

artículo científico publicado en 2007

Hepatitis B virus genotype G and liver fibrosis progression in chronic hepatitis B and human immunodeficiency virus coinfection

artículo científico publicado en 2018

Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells.

artículo científico publicado en 2011

Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility.

artículo científico publicado en 2009

Hepatitis B virus infection enhances susceptibility toward adeno-associated viral vector transduction in vitro and in vivo.

artículo científico publicado en 2014

Hepatitis B virus mutation pattern rtL180M+A181C+M204V may contribute to entecavir resistance in clinical practice

artículo científico publicado en 2019

Hepatitis B virus replication in primary macaque hepatocytes: crossing the species barrier toward a new small primate model.

artículo científico publicado en 2010

Hepatitis B virus resistance to antiviral drugs: where are we going? ⬇️

artículo científico publicado el 1 de enero de 2011

Hepatitis B virus resistance to antivirals: clinical implications and management.

artículo científico publicado en 2003

Hepatitis B virus resistance to nucleos(t)ide analogues.

artículo científico publicado en 2009

Hepatitis B virus wild-type and rtN236T populations show similar early HBV DNA decline in adefovir refractory patients on a tenofovir-based regimen.

artículo científico publicado en 2012

Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infection

artículo científico publicado en 2019

Hepatitis B: reflections on the current approach to antiviral therapy.

artículo científico publicado en 2008

Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma: a cross-sectional study in Lyon, France.

artículo científico publicado en 2004

Hepatitis C virus infection propagates through interactions between Syndecan-1 and CD81 and impacts the hepatocyte glycocalyx.

artículo científico publicado en 2016

Hepatitis C virus treatment in the real world: optimising treatment and access to therapies.

artículo científico publicado en 2015

Hepatitis C virus-induced hepatocarcinogenesis.

scientific article published on 23 May 2009

Hepatitis delta: Clinical aspects and therapeutic perspectives

artículo científico publicado en 2017

Hepatitis: Treatment failure in chronic hepatitis B

artículo científico publicado en 2011

Hepatocellular carcinoma-associated depletion of the netrin-1 receptor Uncoordinated Phenotype-5A (UNC5A) skews the hepatic unfolded protein response towards prosurvival outcomes.

artículo científico publicado en 2017

Heterogeneity of hepatitis B virus (HBV) core gene in a patient with HBV-associated cirrhosis and serum negativity for anti-HBc.

artículo científico publicado en 1996

High incidence of treatment-induced and vaccine-escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B-infected patients

artículo científico publicado en 2013

Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia

artículo científico publicado en 2014

How to improve access to therapy in hepatitis B patients.

artículo científico publicado en 2018

How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualized approach?

artículo científico publicado en 2017

Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients

scientific article published on 20 February 2019

Identifying patients infected with hepatitis B virus in sub-Saharan Africa: potential for misclassification

artículo científico publicado en 2015

Immune-modulators to combat hepatitis B virus infection: From IFN-α to novel investigational immunotherapeutic strategies

artículo científico

Impact of deletions and mutations in Hepatitis B virus envelope proteins on serological profile and clinical evolution.

artículo científico publicado en 2017

Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countries.

artículo científico publicado en 2016

In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2',3'-dideoxy-3'-fluoroguanosine.

artículo científico publicado en 2006

In vivo electroporation improves therapeutic potency of a DNA vaccine targeting hepadnaviral proteins

artículo científico publicado en 2012

In vivo infectivity of liver extracts after resolution of hepadnaviral infection following therapy associating DNA vaccine and cytokine genes.

artículo científico publicado en 2012

Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy

artículo científico publicado en 2015

Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease

artículo científico publicado en 2022

Inhibition of hepatitis B virus gene expression: a step towards functional cure

artículo científico publicado en 2017

Inhibition of the binding of HCV serum particles to human hepatocytes by E1E2-specific D32.10 monoclonal antibody.

artículo científico publicado en 2009

Inhibitory effect of 2'-fluoro-5-methyl-beta-L-arabinofuranosyl-uracil on duck hepatitis B virus replication.

artículo científico publicado en 1998

Innate antiviral immune responses to hepatitis B virus.

artículo científico

Innate response to hepatitis B virus infection: Observations challenging the concept of a stealth virus

article

Interaction between TLR9-CpG-ODNs and HBV virions leads to entry inhibition in hepatocytes and reduction of IFNα production by pDC.

artículo científico publicado en 2018

Interferon‐Ribavirin in Association with Stavudine Has No Impact on Plasma Human Immunodeficiency Virus (HIV) Type 1 Level in Patients Coinfected with HIV and Hepatitis C Virus: A CORIST‐ANRS HC1 Trial ⬇️

artículo científico publicado el 9 de mayo de 2003

Interplay between hepatitis B virus and TLR2-mediated innate immune responses: Can restoration of TLR2 functions be a new therapeutic option? ⬇️

artículo científico publicado el 21 de junio de 2012

Intrafamilial prevalence of hepatitis B virus in Western Brazilian Amazon region: epidemiologic and biomolecular study.

artículo científico publicado en 2006

Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.

artículo científico publicado en 2016

Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients

artículo científico publicado en 2012

LARP1 binding to hepatitis C virus particles is correlated with intracellular retention of viral infectivity

scientific article published on 06 August 2019

Late hepatitis B reactivation following DAA-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient.

artículo científico publicado en 2017

Learning from HIV: how will drug resistance influence treatment strategies against hepatitis C?

artículo científico publicado en 2007

Liver capsule: Validated and potential novel targets to treat hepatitis B virus

artículo científico publicado en 2015

Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence

artículo científico publicado en 2003

Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients.

artículo científico publicado en 2013

Long-term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate

artículo científico publicado en 2005

Long-term results of liver transplantation for Wilson's disease

scientific article published on 10 April 2008

Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.

artículo científico publicado en 2005

Low incidence of precore W28* mutant variants in treated hepatitis B virus and human immunodeficiency virus co-infected patients

artículo científico publicado en 2017

Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire

artículo científico publicado en 2015

Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV.

artículo científico publicado en 2006

Management of antiviral resistance in patients with chronic hepatitis B.

artículo científico publicado en 2004

Management of treatment failure in chronic hepatitis B.

artículo científico publicado en 2012

Markedly effective local control of hepatocellular carcinoma with a poor prognosis by combined multimodal therapy with sorafenib as a neoadjuvant approach.

artículo científico publicado en 2010

Meeting the Challenge of Eliminating Chronic Hepatitis B Infection.

artículo científico publicado en 2019

Microarray for hepatitis B virus genotyping and detection of 994 mutations along the genome.

artículo científico publicado en 2010

Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance

artículo científico publicado en 2014

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination.

artículo científico publicado en 2017

Molecular genetics of HBV infection.

artículo científico publicado en 2010

N-glycosylation mutations within hepatitis B virus surface major hydrophilic region contribute mostly to immune escape.

artículo científico publicado en 2013

Netrin-1 Protects Hepatocytes Against Cell Death Through Sustained Translation During the Unfolded Protein Response

artículo científico publicado en 2016

New HBV subgenotype D9, a novel D/C recombinant, identified in patients with chronic HBeAg‐negative infection in Eastern India ⬇️

artículo científico publicado el 4 de septiembre de 2012

New anti-HCV agents in the pipeline.

artículo científico publicado en 2014

New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus

artículo científico publicado en 2016

New approaches to the management of hepatitis C in haemophilia in 2012.

artículo científico publicado en 2012

New challenges in viral hepatitis.

artículo científico

New nucleic acid diagnostic tests in viral hepatitis.

artículo científico publicado en 2006

New virologic tests and their application in management of chronic hepatitis B

artículo científico publicado en 2006

Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir).

artículo científico publicado en 2016

Non-F HBV/HDV-3 coinfection is associated with severe liver disease in Western Brazilian Amazon

scientific article published on 11 February 2019

Non-invasive biomarkers for chronic hepatitis B virus infection management

scientific article published on 06 July 2019

Non-virological factors are drivers of Hepatocellular Carcinoma in virosuppressed Hepatitis B cirrhosis: results of ANRS CO12 CirVir cohort

artículo científico publicado en 2019

Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle

artículo científico publicado en 2018

Novel targets for hepatitis B virus therapy

artículo científico publicado en 2017

Nucleoside analogs in the treatment of chronic viral hepatitis. Efficiency and complications.

artículo científico publicado en 1994

Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance.

artículo científico publicado en 2013

Pathobiology of HBV mutants and clinical impact for treatment monitoring.

artículo científico publicado en 2009

Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.

artículo científico publicado en 2016

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

artículo científico publicado en 2004

Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells.

artículo científico publicado en 2009

Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B

artículo científico publicado en 2000

Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications

artículo científico publicado en 2014

Perspectives and limitations for nucleo(t)side analogs in future HBV therapies

artículo científico publicado en 2018

Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma ⬇️

artículo científico publicado el 16 de septiembre de 2010

Phytohemagglutinin and concanavalin A activate hepatitis B virus in peripheral blood mononuclear cells of patients with chronic hepatitis B virus infection

artículo científico publicado el 1 de agosto de 1992

Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.

artículo científico publicado en 2012

Polo-like-kinase 1 is a proviral host-factor for hepatitis B virus replication

artículo científico publicado en 2017

Potent inhibition of late stages of hepadnavirus replication by a modified cell penetrating peptide

artículo científico publicado en 2012

Potential effect of lamivudine-induced S gene mutations on liver-related pathogenesis in hepatitis D virus infection.

artículo científico publicado en 2017

PreS1 antigen/antibody patterns following interferon therapy in acute and chronic hepatitis B

artículo científico publicado en 1994

Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa.

artículo científico publicado en 2018

Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg-negative chronic hepatitis B

artículo científico publicado en 2019

Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins

artículo científico publicado en 2006

Present and future therapies of hepatitis B: From discovery to cure

artículo científico publicado en 2015

Prevalence of renal abnormalities in chronic HBV infection: the HARPE study.

artículo científico publicado en 2014

Primary Resistance of Hepatitis B Virus to Nucleoside and Nucleotide Analogues

scientific article published on 14 November 2018

Probable corticosteroid-induced reactivation of latent hepatitis B virus infection in an HIV-positive patient involving immune escape.

artículo científico publicado en 2012

Progress in DNA vaccine for prophylaxis and therapy of hepatitis B.

artículo científico publicado en 2003

Progress towards elimination goals for viral hepatitis

scientific article published on 23 July 2020

Protease inhibitor‐based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver ⬇️

artículo científico publicado el 14 de agosto de 2012

Protein-peptide arrays for detection of specific anti-hepatitis D virus (HDV) genotype 1, 6, and 8 antibodies among HDV-infected patients by surface plasmon resonance imaging.

artículo científico publicado en 2015

Quantification of HBsAg in nucleos(t)ide-naïve patients treated for chronic hepatitis B with entecavir with or without tenofovir in the BE-LOW study.

artículo científico publicado en 2014

Quantification of hepatitis B e antigen between Elecsys HBeAg and Architect HBeAg assays among patients infected with hepatitis B virus.

artículo científico publicado en 2013

Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus

artículo científico publicado en 2015

Reasons to consider earlier treatment of chronic HBV infections

scientific article published on 06 December 2011

Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting

artículo científico publicado en 2019

Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains

artículo científico publicado en 2009

Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the hepatitis C virus

artículo científico

Recovery of chronic hepatitis B- delta infection by zidovudine and recombinant interferon alpha combination therapy in a patient with Kaposi's sarcoma associated with HIV infection

artículo científico publicado en 1992

Remodeling of B-Cell Subsets in Blood during Pegylated IFNα-2a Therapy in Patients with Chronic Hepatitis B Infection.

artículo científico publicado en 2016

Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testing.

artículo científico publicado en 2005

Response‐guided and ‐unguided treatment of chronic hepatitis C ⬇️

artículo científico publicado el 1 de febrero de 2012

Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase

artículo científico publicado en 1994

Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methotrexate and interferon

scientific article published on 26 April 2005

Ribavirin at the Era of Novel Direct Antiviral Agents for the Treatment of Hepatitis C Virus Infection: Relevance of Pharmacological Monitoring

scholarly article by Pierre-François Pradat et al published 2014 in Advances in hepatology

Ribavirin monotherapy in patients with chronic hepatitis C: a retrospective study of 95 patients ⬇️

artículo científico publicado el 1 de mayo de 1998

Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes

artículo científico publicado en 2015

Rise in gamma interferon expression during resolution of duck hepatitis B virus infection.

artículo científico publicado en 2006

Role of RNA in enzymatic activity of the reverse transcriptase of hepatitis B viruses.

artículo científico publicado en 1994

Rolling circle amplification, a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA.

artículo científico publicado en 2008

Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort

article

Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial

artículo científico publicado en 2019

Sarcoidosis and hepatitis C: clinical description of 11 cases.

artículo científico publicado en 2010

Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient.

artículo científico publicado en 2003

Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient.

artículo científico publicado en 2006

Selection of hepatitis B virus (HBV) vaccine escape mutants in HBV-infected and HBV/HIV-coinfected patients failing antiretroviral drugs with anti-HBV activity.

artículo científico publicado en 2007

Selective detection of human hepatitis B virus surface and core antigens in some peripheral blood mononuclear cell subsets by flow cytometry

artículo científico publicado el 1 de enero de 1992

Selective inhibition of the duck hepatitis B virus by a new class of tetraazamacrocycles ⬇️

artículo científico publicado el 1 de noviembre de 1997

Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients

scientific article published on 07 December 2018

Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.

artículo científico publicado en 2008

Similar evolution of hepatitis B virus quasispecies in patients with incomplete adefovir response receiving tenofovir/emtricitabine combination or tenofovir monotherapy.

artículo científico publicado en 2013

Sofosbuvir plus daclatasvir with or without ribavirin for chronic hepatitis C infection: Impact of drug concentration on viral load decay

artículo científico publicado en 2016

Sofosbuvir-based regimens are suboptimal in patients with genotype 2 chronic hepatitis C infection: Real-life experience from the HEPATHER ANRS CO22 cohort

scientific article published on 21 May 2020

Standardized one-step real-time reverse transcription-PCR assay for universal detection and quantification of hepatitis delta virus from clinical samples in the presence of a heterologous internal-control RNA.

artículo científico publicado en 2012

Strategies to inhibit entry of HBV and HDV into hepatocytes.

artículo científico publicado en 2014

Study of HBV replication capacity in relation to sequence variation in the precore and core promoter regions.

artículo científico publicado en 2004

Suboptimal response to adefovir dipivoxil therapy for chronic hepatitis B in nucleoside-naive patients is not due to pre-existing drug-resistant mutants.

artículo científico publicado en 2008

Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir.

artículo científico publicado en 2005

Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure.

artículo científico publicado en 2005

Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis

artículo científico publicado en 2019

Synthesis of 1,2,3-triazolo-carbanucleoside analogues of ribavirin targeting an HCV in replicon.

artículo científico publicado en 2003

Synthesis of 5-haloethynyl- and 5-(1,2-dihalo)vinyluracil nucleosides: antiviral activity and cellular toxicity.

artículo científico publicado en 2005

T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients

artículo científico publicado en 2015

Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients

scientific article published on 14 February 2017

Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection.

artículo científico publicado en 2010

The CUPIC algorithm: an accurate model for the prediction of sustained viral response under telaprevir or boceprevir triple therapy in cirrhotic patients

artículo científico publicado en 2015

The Potential Implication of the Autonomic Nervous System in Hepatocellular Carcinoma

scientific article published on 11 April 2019

The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals.

artículo científico publicado en 2017

The negative impact of HBV/HCV coinfection on cirrhosis and its consequences

artículo científico publicado en 2017

The prophylaxis of hepatocellular carcinoma by interferon-alpha in virus-induced cirrhosis

artículo científico publicado en 2000

The role of nucleoside and nucleotide analogues in nodular regenerative hyperplasia in HIV-infected patients: A case control study ⬇️

artículo científico publicado el 19 de septiembre de 2010

The variability of hepatitis B envelope is associated with HBs antigen persistence in either chronic or acute HBV genotype A infection.

artículo científico publicado en 2017

Therapeutic strategies for hepatitis B virus infection: towards a cure

scientific article published on 27 August 2019

Toll-Like Receptor 7 Agonist GS-9620 Induces Prolonged Inhibition of HBV via a Type I Interferon-Dependent Mechanism

artículo científico publicado en 2017

Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.

artículo científico publicado en 2015

Towards an improved and cost-saving prophylaxis of hepatitis B virus recurrence after liver transplantation?

artículo científico publicado en 2003

Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.

artículo científico publicado en 2007

Treatment of hepatitis C

artículo científico publicado en 2005

Treatment of human immunodeficiency virus and hepatitis B virus infections ⬇️

artículo científico publicado el 1 de julio de 2012

Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study

scientific article published on 25 June 2020

Ultradeep pyrosequencing and molecular modeling identify key structural features of hepatitis B virus RNase H, a putative target for antiviral intervention

artículo científico publicado en 2013

Update of the statements on biology and clinical impact of occult hepatitis B virus infection

artículo científico publicado en 2019

Validation of the INNO-LiPA HBV DR assay (version 2) in monitoring hepatitis B virus-infected patients receiving nucleoside analog treatment.

artículo científico publicado en 2010

Variability in the precore and core promoter regions of HBV strains in Morocco: characterization and impact on liver disease progression

artículo científico publicado en 2012

Variable expression of preS1 antigen in serum during chronic hepatitis B virus infection: an accurate marker for the level of hepatitis B virus replication.

artículo científico publicado en 1990

Very late relapse of hepatitis C virus infection immediately after liver transplant

artículo científico publicado en 2018

Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells.

artículo científico publicado en 2013

Viral hepatitis

scientific article published on 01 October 1999

Viral quasispecies quantitative analysis: a novel approach for appraising the immune tolerant phase of chronic hepatitis B virus infection

artículo científico publicado en 2021

Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis.

artículo científico publicado en 2012

Woodchuck hepatitis virus-induced carcinoma as a relevant natural model for therapy of human hepatoma ⬇️

artículo científico publicado el 1 de junio de 1997

[Clinical and virological evaluation of the detection of pre-S1 and pre-S2 antigens in serum from patients with chronic hepatitis B]

artículo científico publicado en 1995

[Definitions of resistance to analogue antiviral drugs in the treatment of chronic hepatitis B]

artículo científico publicado en 2006

[Effects and risks of prolonged antiviral treatments: the example of chronic hepatitis B]

artículo científico publicado en 1997

[Experimental models for the study of hepadnaviruses and antiviral strategies]

scientific article published on 01 February 1995

[Feedback from two French addiction centers and national survey on the intranasal naloxone (Nalscue®) in the prevention of opioid overdoses]

scientific article published on 24 January 2019

[Hepatitis B virus reactivation after allogeneic bone marrow transplantation in a patient previously cured of hepatitis B]

artículo científico publicado en 1999

[Hepatitis C virus infection and thyroid diseases]

artículo científico publicado en 1999

[Hepatitis C virus]

artículo científico publicado en 2000

[Long-term treatment with lamivudine for chronic hepatitis B]

scientific article published on 01 December 2000

[New therapeutic advances in chronic hepatitis B]

artículo científico publicado en 2003

[Prevention of liver fibrosis and liver cancer linked to hepatitis B virus in Africa: the Prolifica study]

artículo científico publicado en 2019

[Results of a satisfaction survey carried out among patients living with the virus of human immunodeficiency (HIV) following therapeutic education sessions]

scientific article published on 06 July 2010

[Towards new therapeutic concepts to fight against chronic hepatitis B]

artículo científico publicado en 2016

[Treatment of hepatitis B. Therapeutic management]

scientific article published on 09 May 2008

[Treatment of hepatitis B: new perspectives]

scientific article published on 27 June 2009

[Treatment of hepatitis C: decisive therapeutic advances]

[Viral hepatitis].

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda